Overview

An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, non-randomized, single dose of 14C-NW-3509 capsule study in 6 healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Newron Pharmaceuticals SPA